Suchergebnisse - "Jia, Qingmei"

PubPharm (60)

11

Safe potent single platform vaccine against Tier 1 select agents and other pathogens

enthalten in: Europäisches Patentamt | 2022

von HORWITZ MARCUS A | JIA QINGMEI

12

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters

enthalten in: bioRxiv.org | 2021

von Jia, Q. | Bielefeldt-Ohmann, H. | Maison, R. | +3

13

SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19

enthalten in: Europäisches Patentamt | 2021

von HORWITZ MARCUS | JIA QINGMEI

14

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

enthalten in: Behavioural brain research | 2021

von Guo, M. | Xiang, T. | Li, M. | +10

15

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

enthalten in: NPJ vaccines | 2021

von Jia, Q. | Bielefeldt-Ohmann, H. | Maison, R. | +4

UpdateOf: bioRxiv. 2020 Nov 18;:. - PMID 33236013

16

Roles of Motor Cortex Neuron Classes in Reach-Related Modulation for Hemiparkinsonian Rats

enthalten in: Frontiers in neuroscience | 2021

von Li, M. | Wang, X. | Yao, X. | +13

17

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters

enthalten in: bioRxiv : the preprint server for biology | 2020

von Jia, Q. | Bielefeldt-Ohmann, H. | Maison, R. | +3

UpdateIn: NPJ Vaccines. 2021 Mar 30;6(1):47. - PMID 33785745

18

State-Dependent Spike and Local Field Synchronization between the Thalamic Parafascicular Nucleus and the Dorsal Striatum in a Rat Model of Parkinson's Disease

enthalten in: Neuroscience | 2019

von Zhang, H. | Yang, J. | Xiang, T. | +8

19

NOVEL LIVE RECOMBINANT BOOSTER VACCINE AGAINST TUBERCULOSIS

enthalten in: Europäisches Patentamt | 2018

von HORWITZ MARCUS A | JIA QINGMEI

20

Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia

enthalten in: Scientific reports | 2018

von Jia, Q. | Bowen, R. | Dillon, B. | +4